These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17573897)
1. Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance. Shang D; Liu Y; Ito N; Kamoto T; Ogawa O Cancer Sci; 2007 Aug; 98(8):1259-64. PubMed ID: 17573897 [TBL] [Abstract][Full Text] [Related]
2. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668 [TBL] [Abstract][Full Text] [Related]
3. Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling. Shang D; Yang P; Liu Y; Song J; Zhang F; Tian Y Cancer Invest; 2011 Jun; 29(5):347-52. PubMed ID: 21599510 [TBL] [Abstract][Full Text] [Related]
4. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells. Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 induces drug resistance in renal cell carcinoma. Ishibashi K; Koguchi T; Matsuoka K; Onagi A; Tanji R; Takinami-Honda R; Hoshi S; Onoda M; Kurimura Y; Hata J; Sato Y; Kataoka M; Ogawsa S; Haga N; Kojima Y Fukushima J Med Sci; 2018 Dec; 64(3):103-110. PubMed ID: 30369518 [TBL] [Abstract][Full Text] [Related]
7. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. Beadling C; Guschin D; Witthuhn BA; Ziemiecki A; Ihle JN; Kerr IM; Cantrell DA EMBO J; 1994 Dec; 13(23):5605-15. PubMed ID: 7988557 [TBL] [Abstract][Full Text] [Related]
8. Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling. Kitagawa Y; Yamaguchi M; Kohno M; Sakai M; Itoh M; Gotoh B FEBS Lett; 2020 Mar; 594(5):864-877. PubMed ID: 31705658 [TBL] [Abstract][Full Text] [Related]
9. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon. Hazari S; Taylor L; Haque S; Garry RF; Florman S; Luftig R; Regenstein F; Dash S Virol J; 2007 Sep; 4():89. PubMed ID: 17877826 [TBL] [Abstract][Full Text] [Related]
10. Suppression of interferon-α signaling by hepatitis E virus. Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878 [TBL] [Abstract][Full Text] [Related]
11. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction. Bisson SA; Page AL; Ganem D J Virol; 2009 May; 83(10):5056-66. PubMed ID: 19279093 [TBL] [Abstract][Full Text] [Related]
12. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. Wong LH; Krauer KG; Hatzinisiriou I; Estcourt MJ; Hersey P; Tam ND; Edmondson S; Devenish RJ; Ralph SJ J Biol Chem; 1997 Nov; 272(45):28779-85. PubMed ID: 9353349 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C. Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454 [TBL] [Abstract][Full Text] [Related]
14. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells. Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551 [TBL] [Abstract][Full Text] [Related]
15. Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway. Yang CH; Murti A; Valentine WJ; Du Z; Pfeffer LM J Biol Chem; 2005 Jul; 280(27):25849-53. PubMed ID: 15883164 [TBL] [Abstract][Full Text] [Related]
16. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. Lin RJ; Liao CL; Lin E; Lin YL J Virol; 2004 Sep; 78(17):9285-94. PubMed ID: 15308723 [TBL] [Abstract][Full Text] [Related]
17. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853 [TBL] [Abstract][Full Text] [Related]
18. Constitutive STAT1 tyrosine phosphorylation in U937 monocytes overexpressing the TYK2 protein tyrosine kinase does not induce gene transcription. Eilers A; Kanda K; Klose B; Krolewski J; Decker T Cell Growth Differ; 1996 Jun; 7(6):833-40. PubMed ID: 8780896 [TBL] [Abstract][Full Text] [Related]
19. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Sancéau J; Hiscott J; Delattre O; Wietzerbin J Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594 [TBL] [Abstract][Full Text] [Related]
20. Escherichia coli infection activates the production of IFN-α and IFN-β via the JAK1/STAT1/2 signaling pathway in lung cells. Jin Y; Jia Z; Cai Q; Sun Y; Liu Z Amino Acids; 2021 Oct; 53(10):1609-1622. PubMed ID: 34524541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]